Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma (Q39060215)
Jump to navigation
Jump to search
scientific article published on December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma |
scientific article published on December 2013 |
Statements
1 reference
Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma (English)
1 reference
Yoshinari Shinsato
1 reference
Tatsuhiko Furukawa
1 reference
Shunji Yunoue
1 reference
Hajime Yonezawa
1 reference
Kentarou Minami
1 reference
Yukihiko Nishizawa
1 reference
Ryuji Ikeda
1 reference
Kohichi Kawahara
1 reference
Masatatsu Yamamoto
1 reference
Hirofumi Hirano
1 reference
Hiroshi Tokimura
1 reference
Kazunori Arita
1 reference
1 December 2013
1 reference
1 reference
12
1 reference
2261-2270
1 reference
Identifiers
1 reference
1 reference